Plain-English translation of NCT07040657 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether injecting a blue dye (methylene blue) at four locations on the cervix works better than the standard two-location injection for finding sentinel lymph nodes—the first lymph nodes where endometrial cancer may spread. Surgeons use this dye to identify which lymph nodes to remove during cancer surgery. The study will compare how well each injection method helps doctors locate these important nodes.
Currently, the standard two-point injection method doesn't always successfully identify sentinel lymph nodes, which can affect how well surgeons treat endometrial cancer. Researchers want to know if using more injection points will improve the success rate and help surgeons remove the right lymph nodes more reliably.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive either a standard two-point blue dye injection or a four-point injection during your endometrial cancer surgery. The injection happens at the beginning of your operation to help your surgeon identify sentinel lymph nodes. Your surgical team will then observe how well each method works at highlighting the lymph nodes that need to be removed. You will not need extra visits beyond your normal cancer surgery and follow-up care.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Turkey (Türkiye)